Drawing for SIGNIFY CLINICAL NETWORK SERVICES

USPTO serial 88270023

SIGNIFY CLINICAL NETWORK SERVICES

Reviewed by CopyMark Law Group

Status 606
Filing date
Status date
Registration date
—
Examiner
GUTTADAURO, JULIE MARIE
Law office
INTENT TO USE SECTION

What this means

This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.

Need help with SIGNIFY CLINICAL NETWORK SERVICES?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Elisabeth A. Evert

Elisabeth A. Evert HITCHCOCK EVERT LLPP.O. BOX 131709DALLAS, TX 75313-1709UNITED STATES

Goods and services

ClassDescriptionStatusFirst use
035Business and management consulting in the health care field, namely, designing and implementing corporate health care programs; providing health care data analytics to health plans, drug and medical device manufacturers, physicians, long-term care facilities, and employers for the purposes of patient evaluation, care coordination and care management, clinical trial coordination and management, and projected health care utilization; risk management consultation, namely, identifying gaps in patient care and methods for closing the gaps; coordinating, administering, monitoring and reporting for business purposes patient participation in clinical trials and medical device studies for othersACTIVE—
044Health care services, namely, conducting patient health care evaluations, coordinating care and care management, managing complex chronic medical conditions, preventative care, medical testing, and treatment; providing medical care coordination and management services to health plans, drug and medical device manufacturers, physicians, long-term care facilities, employers, and patients; treatment management services, namely, administering and monitoring medication dosing, medical device implementation, and participation in clinical trialsACTIVE—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

Latest event (MAB6): The intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window.

DateCodeEventWhat it means
Apr 26, 2021MAB6ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILEDThe intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window.
Apr 26, 2021ABN6ABANDONMENT - NO USE STATEMENT FILEDThe intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window.
Aug 25, 2020EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
Aug 21, 2020EX1GSOU EXTENSION 1 GRANTED—
Aug 21, 2020EXT1SOU EXTENSION 1 FILED—
Aug 21, 2020EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Mar 24, 2020NOAMNOA E-MAILED - SOU REQUIRED FROM APPLICANTA Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date.
Jan 28, 2020NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Jan 28, 2020PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Jan 8, 2020NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
Dec 23, 2019ALIEASSIGNED TO LIE—
Dec 19, 2019CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Dec 19, 2019XAECEXAMINER'S AMENDMENT ENTERED—
Dec 19, 2019GNENNOTIFICATION OF EXAMINERS AMENDMENT E-MAILED—
Dec 19, 2019GNEAEXAMINERS AMENDMENT E-MAILED—
Dec 19, 2019CNEAEXAMINERS AMENDMENT -WRITTEN—
Jul 27, 2019GNRNNOTIFICATION OF NON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Jul 27, 2019GNRTNON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Jul 27, 2019CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Apr 2, 2019DOCKASSIGNED TO EXAMINER—
Feb 12, 2019NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Jan 24, 2019NWAPNEW APPLICATION ENTERED—

Frequently asked questions

Related guidance